Cogstate Limited (ASX:CGS)
2.180
-0.070 (-3.11%)
At close: Jan 9, 2026
Cogstate Market Cap
Cogstate has a market cap or net worth of 373.99 million as of January 9, 2026. Its market cap has increased by 105.94% in one year.
Market Cap
373.99M
Enterprise Value
320.46M
Revenue
80.98M
Ranking
n/a
PE Ratio
24.52
Stock Price
2.18
Market Cap Chart
Since February 16, 2004, Cogstate's market cap has increased from 4.34M to 373.99M, an increase of 8,512.03%. That is a compound annual growth rate of 22.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 373.99M | -3.54% |
| Dec 31, 2025 | 387.71M | 116.56% |
| Dec 31, 2024 | 179.03M | -27.11% |
| Dec 29, 2023 | 245.63M | -27.75% |
| Dec 30, 2022 | 339.98M | -18.95% |
| Dec 31, 2021 | 419.47M | 124.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.03B |
| Pro Medicus | 21.96B |
| Cochlear | 17.22B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 8.13B |
| Ansell | 4.77B |
| Mesoblast | 3.94B |
| Telix Pharmaceuticals | 3.81B |